• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Cardiome Pharma Corp. (CRME)

    8.85 Up 0.04(0.45%) Aug 28, 3:59PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Cardiome Pharma Corp.
    6th Floor
    Vancouver, BC V6J 4S7
    Canada - Map
    Phone: 604-677-6905
    Fax: 604-677-6915
    Website: http://www.cardiome.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Other
    Full Time Employees:N/A

    Business Summary 

    Cardiome Pharma Corp., a specialty pharmaceutical company, engages in the development and commercialization of cardiovascular therapies that enhance the life and health of patients from heart diseases. It offers BRINAVESS (vernakalant IV) for the conversion of recent onset atrial fibrillation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in acute coronary syndrome patients. It has operations in Canada, the United States, and Europe. The company was formerly known as Nortran Pharmaceuticals Inc. and changed its name to Cardiome Pharma Corp. in June 2001. Cardiome Pharma Corp. was founded in 1986 and is based in Vancouver, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cardiome Pharma Corp.

    Key Executives 
    Dr. William L. Hunter M.D., Msc, BSc, 52
    Chief Exec. Officer, Pres and Director
    Ms. Jennifer Michael Archibald CA,
    Chief Financial Officer
    Ms. Sheila M. Grant MBA,
    Chief Operating Officer
    Mr. David D. McMasters Esq., J.D., 56
    Corp. Gen. Counsel
    Mr. David Dean ,
    VP of Bus. Devel. and Investor Relations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders